CRISPR–Cas13—a class 2 type VI RNA endonuclease with two higher eukaryotes and prokaryotes nucleotide-binding (HEPN) domains for RNA cleavage—targets and degrades RNA. The RNA targeting has been used ...
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a ...
Researchers have engineered a new class of adenine base editors that reduce unwanted bystander mutations by two to three ...
Whole-brain genome editing to correct single-base mutations and reduce or reverse behavioral changes in animal models of autism spectrum disorder (ASD) has now been achieved. Fudan University and ...
The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...